Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals

Although required for many fundamental immune processes, ranging from self-tolerance to pathogen immunity, interleukin (IL)-2 production is transient, and the mechanisms underlying this brevity remain unclear. These studies reveal that helper T cell IL-2 production is limited by a classic negative feedback loop that functions autonomously or in collaboration with other common γ chain (IL-4 and IL-7) and IL-6/IL-12 family cytokines (IL-12 and IL-27). Consistent with this model for cytokine-dependent regulation, they also demonstrate that the inhibitory effect can be mediated by several signal transducer and activator of transcription (STAT) family transcription factors, namely STAT5, STAT4, and STAT6. Collectively, these findings establish that IL-2 production is limited by a network of autocrine and paracrine signals that are readily available during acute inflammatory responses and, thus, provide a cellular and molecular basis for its transient pattern of expression.

[1]  A. Chang,et al.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. , 1985, The New England journal of medicine.

[2]  T. Malek,et al.  Tolerance, not immunity, crucially depends on IL-2 , 2004, Nature Reviews Immunology.

[3]  Ronald H. Schwartz,et al.  Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process , 2003, Nature Immunology.

[4]  L. Hennighausen,et al.  Stat5a/b are essential for normal lymphoid development and differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Waldmann,et al.  Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. , 2001, Immunity.

[6]  B. Groner,et al.  The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain. , 1998, The Journal of biological chemistry.

[7]  R. Kastelein,et al.  IL-27 Limits IL-2 Production during Th1 Differentiation1 , 2006, The Journal of Immunology.

[8]  M. Grilli,et al.  NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. , 1992, Science.

[9]  Kendall A. Smith,et al.  Interleukin-2: inception, impact, and implications. , 1988, Science.

[10]  B. Groner,et al.  The Interleukin-4 Receptor Activates STAT5 by a Mechanism That Relies upon Common γ-Chain* , 1998, The Journal of Biological Chemistry.

[11]  M. Lenardo.  Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. , 1991, Nature.

[12]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[13]  A. Tyznik,et al.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells , 2006, Nature.

[14]  W. Paul,et al.  Stat5 activation plays a critical role in Th2 differentiation. , 2003, Immunity.

[15]  A. Rao,et al.  Transcriptional regulation of the IL-2 gene. , 1995, Current opinion in immunology.

[16]  W. Leonard.  Cytokines and immunodeficiency diseases , 2001, Nature Reviews Immunology.

[17]  Ronald H. Schwartz,et al.  IL-2 Secretion by CD4+ T Cells In Vivo Is Rapid, Transient, and Influenced by TCR-Specific Competition , 2004, The Journal of Immunology.

[18]  G. Freeman,et al.  p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes , 2000, Nature Medicine.

[19]  C. Hunter.  New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions , 2005, Nature Reviews Immunology.

[20]  J. Lohr,et al.  Sequential development of interleukin 2–dependent effector and regulatory T cells in response to endogenous systemic antigen , 2005, The Journal of experimental medicine.

[21]  R. Schwartz,et al.  Smad3 Is Essential for TGF-β1 to Suppress IL-2 Production and TCR-Induced Proliferation, but Not IL-2-Induced Proliferation1 , 2004, The Journal of Immunology.

[22]  S. Efrat,et al.  Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. Paul,et al.  Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Glimcher,et al.  IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508 , 2005, The Journal of experimental medicine.

[25]  Naoto Hirano,et al.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells , 2001, Nature Immunology.

[26]  T. Mosmann,et al.  In Vivo Priming of Cd4 T Cells That Produce Interleukin (Il)-2 but Not IL-4 or Interferon (Ifn)-γ, and Can Subsequently Differentiate into IL-4–Or IFN-γ–Secreting Cells , 2001, The Journal of experimental medicine.

[27]  L. Bradley,et al.  IL-7: maintaining T-cell memory and achieving homeostasis. , 2005, Trends in immunology.

[28]  F. Liew.  TH1 and TH2 cells: a historical perspective , 2002, Nature Reviews Immunology.

[29]  G. Freeman,et al.  The B7 family revisited. , 2005, Annual review of immunology.

[30]  J. Mier,et al.  Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Lempicki,et al.  Interleukin‐2 induced immune effects in human immunodeficiency virus‐infected patients receiving intermittent interleukin‐2 immunotherapy , 2001, European journal of immunology.